***Live: Wednesday, October 28, 2020, 11am EDT| 8am PDT| 3pm GMT| 4pm CET*** Discover a new and unique tool to assess the variances in mAb glycoforms and their differences in potency and efficacy using an affinity Fc-Receptor based chromatographic methodology. Data obtained can be correlated to ADCC activity. *** On demand available after final airing until Oct. 28, 2021.***
Register free: https://www.chromatographyonline.com/lcgc_w/simple_fast
Event Overview:
Biological activity of monoclonal antibodies (mAbs) is substantially affected by post-translational modifications that include glycosylation of highly conserved Asn-297 in the Fc-region. Therefore, glycosylation is considered a critical quality attribute (CQA) and must be monitored and characterized as an essential part of biopharmaceutical development. Glycosylation is a critical factor in drug product solubility, kinetics, stability, efficacy, and immunogenicity. Analytical methods utilize a suite of chromatographic modes using high performance liquid chromatography (HPLC) to analyze glycosylation of both intact and digested protein molecules.
Key Learning Objectives:
To learn the principles of micro-chip-based pillar array chromatography columns.
Speakers: Philip Hoang, Technical Marketing-Analytical Chromatography, Tosoh Bioscience
Scott Melideo, Ph.D., Applications Scientist, Tosoh Bioscience
Time and Date: Wednesday, October 28, 2020, 11am EDT | 8am PDT | 3pm GMT | 4pm CET
On demand available after final airing until Oct. 28, 2021
Sponsor: Tosoh Bioscience
Register free: https://www.chromatographyonline.com/lcgc_w/simple_fast